Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 3
1(25.0%)
Phase 2
1(25.0%)
4Total
N/A(2)
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07642362Not ApplicableRecruiting

Digital Support for Multiple Myeloma Quality of Life

Role: lead

NCT07642375Not ApplicableRecruiting

Study of the Impact of Digital Health Interventions on Symptom & Side-Effect Management in Metastatic Sarcoma Patients

Role: lead

NCT06044623Phase 3Recruiting

Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients

Role: collaborator

NCT04879563Phase 2Active Not Recruiting

Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project

Role: collaborator

All 4 trials loaded